Skip to main content
Log in

Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The important components of mucopolysaccharides and collagen have been analyzed in tissues of control and carcinoma of uterine cervix. Among these components hyaluronic acid and chondroitin sulphate levels were found to be increased, whereas decreased level of collagen was observed in uterine cervical carcinoma. Serum cathepsin B, D and acid and alkaline phosphatases have also been analyzed in controls and carcinoma patients before and after treatments. The activities of these enzymes have been found to increase prominently in advanced stages. Among these enzymes cathepsin B and alkaline phosphatase have exhibited remarkable increase in activity in uterine cervical carcinoma. Different modes of treatment exerted reversion of the elevated activities of these enzymes. However, combined therapy type II (radiation combined with cisplatin and cyclophosphomide) seems to be more effective in reverting the activities of these enzymes to normal levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bernfield MR, Benerjee SD: Acid mucopolysaccaride (glycosaminoglycan) at the epithelial mesenchymal interface of mouse embryo salivary glands. J Cell Biol 52: 674–682, 1972

    PubMed  Google Scholar 

  2. Brunish R, Asboe-Hansen G: Acid mucopolysaccaride in the Rask-Nielsen tranplantable mouse mastocytoma. Acta Pathol Microbiol Immunol Scand 65: 185–191, 1965

    Google Scholar 

  3. Asokan R, Chandrakasan G, Puvanakrishnan R, Dhar SC: Separation and evaluation of changing pattern of glycosaminoglycan in 2-methyl cholanthrene induced fibrosarcoma. Neoplasm 36: 273–279, 1989

    Google Scholar 

  4. Kojima J, Nakamura N, Kanatani M, Ohmori K: The glycosaminoglycan in human hepatic cancer. Cancer Res 35: 542–547, 1975

    PubMed  Google Scholar 

  5. Takashi N, Fujii J, Shinsuke T, Yoshiki A, Kenji N, Takeshi H, Toshi Kazu H, Kazuya H: Glycosaminoglycan in malignant pleural mesothelioma. Cancer 57: 106–112, 1986

    PubMed  Google Scholar 

  6. Shankaranarayanan R: Biochemical studies on human gastric carcinoma. Ph. D. Thesis, University of Madras, 1989

  7. Liotta LA, Nageswara Raco C and Wewer UM: Biochemical interaction of tumor cells with the basement membranes. Ann Rev Biochem 55: 1037–1057, 1986

    PubMed  Google Scholar 

  8. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC and Miskin R: Effects of inhibitors of plasminogen activator, serine proteinases and collagenase-IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307–3312, 1988

    PubMed  Google Scholar 

  9. Kefalide NA: Isolation of a collagen from basement membrane containing three α-chains. Biochem Biophys Res Commun 45: 226–234, 1971

    PubMed  Google Scholar 

  10. Nicolson GL and Poster G: Tumor implantation and invasion at metastatic site. Int Rev Exp Pathol 25: 77–81, 1983

    PubMed  Google Scholar 

  11. Liotta LA, Rao CN and Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 49: 636–649, 1983

    PubMed  Google Scholar 

  12. Nicolson GL: Cancer metastasis: Organ colonization and the cell surface properties of malignant cells. Biochem Biophys Acta 695: 113–176, 1982

    PubMed  Google Scholar 

  13. Jones PA and Declerck YA: Extracellular matrix degradation by invasive tumor cells. Cancer Metastasis Rev 1: 289–317, 1982

    PubMed  Google Scholar 

  14. Kerbel R, Frost P and Greig R: The significance of biological heterogenicity or cellular interaction in metastasis. Cancer Metastasis Rev 9: 1–34, 1990

    PubMed  Google Scholar 

  15. Roden L, Baker JR, Cifonelli JA and Methew MB: Isolation and characterization of connective tissue polysaccharide. Methods in Enzymol 28: 73–146, 1972

    Google Scholar 

  16. Bitter T and Muir HM: A modified uronic acid carbazole reaction. Anal Biochem 4: 330–334, 1962

    PubMed  Google Scholar 

  17. Miller EJ and Rhodes RK: Preparation and characterization of different types of collagen. Methods in Enzymol 82: 33–65, 1982

    Google Scholar 

  18. Newman RE and Logan MA: The determination of hydroxyproline. J Biol Chem 184: 299–306, 1950

    PubMed  Google Scholar 

  19. Barrett AJ: An improved color reagent for use in Barret's assay of cathepsin B. Anal Biochem 76: 374–376, 1976

    PubMed  Google Scholar 

  20. Poole AR: The locations of cathepsin activity and β-glucuronidase in the Guerin T8 tumor. Biochem J 118: 543–549, 1970

    PubMed  Google Scholar 

  21. King J: Assay of alkaline phosphatase. Practical clinical Enzymology, Philadelphia, Van Wostrand, D., Co. London, p. 106–111, 1965

    Google Scholar 

  22. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951

    PubMed  Google Scholar 

  23. Keller KL, Underhill CB, Keller JM: Multiple types of cell surface heparan sulphate are produced by primary cultures of embryonic mouse cells. Biochim Biophys acta 540: 431–442, 1978

    Google Scholar 

  24. Roblin R, Albert SO, Gelb NA and Black PH: Cell surface changes correlate with density-dependent inhibition of glycosaminoglycan metabolism in 3T3, SV-3T3 and Con-A revertent cells. Biochemistry 14: 347–357, 1975

    PubMed  Google Scholar 

  25. Hopwood JJ and Dorfman, A: Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with Simian Virus 40. J Biol Chem 252: 4777–4785, 1977

    PubMed  Google Scholar 

  26. Horai T, Nakamura N, Tateishi R and Hottori S: Glycosaminoglycan in human lung cancer. Cancer 48: 2016–2021, 1981

    PubMed  Google Scholar 

  27. Takeuchi J, Sobue M, Sato E, Shamoto M, Miura K and Nakagaki S: Variations of glycosaminoglycan components of breast tumors. Cancer Res 36: 2133–2138, 1976

    PubMed  Google Scholar 

  28. Satoh C, Duft R and Davidson EA: Production of mucopolysaccharides by normal and transformed cells. Proc Natl Acad Sci 70: 54–56, 1973

    PubMed  Google Scholar 

  29. Symmonds DA: Glycosaminoglycan of human colon in inflammatory and neoplastic condition. Arch Pathol Lab Med 102: 146–149, 1978

    PubMed  Google Scholar 

  30. Sampio LO, Dietrich CP and Filho OG: Changes in sulphated mucopolysaccharide composition of mammalian tissues during growth and in cancer tissues. Biochim Biophys Acta 498: 123–131, 1977

    PubMed  Google Scholar 

  31. Dietrich CP, Sampaio LO and Montes deOea H: Proceedings of the 5th International Symposium on Glycoconjugates, Kiel, 1979. (Eds) Schauer, Boer, Buddecke, Kramer, Kliegenthart and Wiegandt. Pub. George Thielne Publishers, Stuttgart, pp 623–626, 1979

    Google Scholar 

  32. Peterkofsky B and Prather W: Suppression of synthesis of pro-α1(I) and production of altered pro-α2 (I) procollagen subunits in 4-nitroqunoline-1-oxide transformed fibroblasts. J Biol Chem 261: 16818–16826, 1986

    PubMed  Google Scholar 

  33. Sandmeyer S, Smith R, Keihn D and Bornstein P: Correlation of collagen synthesis and procollagen messenger RNA levels with transformation in rat embryo fibroblasts. Cancer Res 41: 830–838, 1981

    PubMed  Google Scholar 

  34. Wu CH, Dono Van CB and Wu GY: Evidence for pretranslational regulation of collagen synthesis by procollagen properties. J Biol Chem 261: 10482–10484, 1986

    PubMed  Google Scholar 

  35. Nakajjma N, Welch DR, Belloni PN and Nicolson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat memory adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869–4876, 1987

    PubMed  Google Scholar 

  36. Buck MR, Karustis DG, Day NA, Honn KV and Sloane BE: Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumor tissues. Biochem J 282: 273–278, 1992

    PubMed  Google Scholar 

  37. Sloane K, Honn KV, Sadler JG, Turner WA, Kimpson JJ and Taylor JD: Cathepsin B activity in B16 melanoma: A possible marker for metastatic potential. Cancer Res 42: 980–986, 1982

    PubMed  Google Scholar 

  38. Scambia G, Benedetti P, Ferrandina G, Battaglia P, Baiocchi G and Mancuso S: Cathepsin D assay in ovarian cancer: Correlation with pathological features and receptors for estrogen, progesterone and epidermal growth factor. Br J Cancer 64: 182–184, 1991

    PubMed  Google Scholar 

  39. Weiss L: Some mechanisms involved in cancer cell detachment by nectrotic material. Int J Cancer 22: 196–203, 1976

    Google Scholar 

  40. Poole AR, Tiltman KJ, Recklies AD and Stokes TAM: Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinoma and fobraodenomas. Nature 273: 545–547, 1978

    PubMed  Google Scholar 

  41. Pietras RJ, Szego CM, Mangam CE, Seeler BJ, Burtnett MM and Orevi M: Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstet Gynaecol 52: 321–327, 1978

    Google Scholar 

  42. Cooper EH: The nature of cancer. Ann Clin Biochem 13: 467–470, 1976

    PubMed  Google Scholar 

  43. Stehman FB: Concurrent chemoradiation in carcinoma of the uterine cervix. Semin Oncol 19: 88–91, 1992

    Google Scholar 

  44. Kresh CR, Constable WC, Spaulding CA, Hahn SS, Anderson WA and Taylor PT: A phase I–II trial of multimodality management of bulky gynecologic malignancy. Cancer 66: 30–34, 1990

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhuvarahamurthy, V., Govindasamy, S. Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma. Mol Cell Biochem 144, 35–43 (1995). https://doi.org/10.1007/BF00926738

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00926738

Key words

Navigation